Colgrove John 4

What Happened John Colgrove, Everpure’s Chief Visionary Officer and a director, received a grant of 78,700 restricted stock units (RSUs) on May 14, 2026. The award was reported as a derivative grant at $0.00 per share (no immediate cash exchanged). These RSUs are performance-based and will only convert to shares if specified stock-price targets are met by set measurement dates.

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (appears to be filed after the typical 2-business-day Form 4 window).
• Transaction type/code: Award/Grant (A); derivative award (long-term performance incentive).
• Shares granted: 78,700 RSUs; reported acquisition price: $0.00; immediate cash value at grant: $0.
• Shares owned after transaction: Not specified in the Form 4.
• Footnote highlights:
  • RSUs are issuable only if the 30-trading-day average closing price of Everpure Class A common stock equals or exceeds $150.00 (adjusted for splits) measured at the end of fiscal years 2029, 2030, or 2031.
  • If achieved, 33%, 67% and 100% of the target shares become earned for 2029, 2030 and 2031 respectively; earned shares vest on March 20 of the applicable year, subject to Colgrove’s continued service.
  • Shares issued on vesting are subject to a one-year post-vest holding period.
  • If the $150 target is not met by the end of fiscal 2031, any unearned shares are forfeited.

Context This is a performance-based equity award, not an open-market purchase or sale. Such awards are common elements of executive compensation and are contingent on future stock-price performance and continued service, so they do not represent an immediate buy/sell decision by the insider. Retail investors should treat this as compensation-related dilution potential if targets are met, rather than a direct bullish or bearish signal.